Treatment results and prognostic factors in patients with malignant fibrous histiocytoma

REFERENCES

• Rosengberg SA. Soft tissue sarcoma of the extremities. In: Sugar-Baker PH, Nicholson TH, eds. Atlas of extremity sarcoma surgery. Philadelphia: JB Lippincott; 1984. p. 1–17.
   Google Scholar
• O'Brien JE, Stout AR Malignant fibrous xanthomas. Cancer 1964; 17: 1445–55.
   PubMed Web of Science ®Google Scholar
• Bertoni F, Capanna R, Biagini R. Malignant fibrous histiocy-toma of soft tissue: an analysis of 78 cases located and deeply seated in the extremities. Cancer 1985; 56: 356–67.
   Google Scholar
• Fagundes HM, Lai PP, Dehner LP, et al. Postoperative radiotherapy for malignant fibrous histiocytoma. Int J Radia-tion Oncology Biol Phys 1992; 23: 615–9.
   PubMedGoogle Scholar
• Gibbs JF, Huang PP, Lee RJ, et al. Malignant fibrous histiocytoma: an institutional review. Cancer Invest 2001; 19: 23–7.
   PubMed Web of Science ®Google Scholar
• Peiper M, Zurakowski D, Knoefel WT, et al. Malignant fibrous histiocytoma of the extremities and trunk: an institutional review. Surgery 2004; 135: 59–66.
   PubMedGoogle Scholar
• Greene FL, Page DL, Fleming ID, et al. AJCC (American Joint Committee on Cancer) cancer staging manual. 6th ed. New York: Springer-Verlag, 2002. p. 221–8.
   Google Scholar
• Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978; 41: 2250–66.
   PubMed Web of Science ®Google Scholar
• Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues: a type of malignant fibrous histiocytoma. Cancer 1972; 29: 961–76.
   PubMed Web of Science ®Google Scholar
• Kyriakos M, Kempson RL. Inflammatory fibrous histiocy-toma: an aggressive and lethal lesion. Cancer 1976; 37: 1584–606.
   PubMed Web of Science ®Google Scholar
• Soule EH, Enriquez. P. Atypical fibrous histiocytoma, malig-nant fibrous histiocytoma, and epithelioid sarcoma: a com-parative study of 65 tumors. Cancer 1972; 30: 128–43.
   PubMedGoogle Scholar
• Guccion JG, Enzinger FM. Malignant giant cell tumor of soft part. Cancer 1972; 20: 1518–29.
   Google Scholar
• Weiss SW, Enzinger FM. Myzoid variant of malignant fibrous histiocytoma. Cancer 1977; 39: 1672–85.
   PubMed Web of Science ®Google Scholar
• Enzinger FM. Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 1979; 44: 2147–57.
   PubMed Web of Science ®Google Scholar
• Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, CA: Lifetime Learning Publications; 1982. p. 284–8.
   Google Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incom-plete observation. J Am Stat Assoc 1958; 53: 457–81.
   Google Scholar
• Lawless JE. Statistical models and methods for lifetime data. New York: Wiley; 1982. p. 420–2.
   Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187–220.
   Google Scholar
• Pezzi CM, Rawlings MS, Esgro JJ, et al. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992; 69: 2098–103.
   PubMedGoogle Scholar
• Belal A, Kandil A, Allam A, et al. Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 2002; 25: 16–22.
   PubMedGoogle Scholar
• Le Pechoux C, Le Deley MC, Delalogue S, et al. Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: results with two different total dose, fractiona-tion, and overall treatment time schedules. Int J Radiat Oncol Biol Phys 1999; 44: 879–86.
   PubMedGoogle Scholar
• Salo JC, Lewis JJ, Woodruff JM, et al. Malignant fibrous histiocytoma of the extremity. Cancer 1999; 85: 1765–72.
   PubMedGoogle Scholar
• Antman KH. Adjuvant therapy of sarcomas of soft tissue. Semin Oncol 1997; 24: 556–60.
   PubMedGoogle Scholar
• Benjamin RS, Terjanian TO, Fenoglio CJ, et al. The impor-tance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In: Salmon SE, ed. Adjuvant therapy of cancer, vol. 5. Orlando: Grune & Stratton; 1987. p. 734–44.
   Google Scholar
• Rosenberg SA, Tepper J, Glatstein E, et al. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 1983; 52: 424–34.
   PubMed Web of Science ®Google Scholar
• Chang AE, Kinsella T, Glatstein E, et al. Adjuvant chemother-apy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol 1988; 6: 1491–500.
   PubMed Web of Science ®Google Scholar
• Gherlinzoni F, Bacci G, Picci P, et al. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol 1986; 4: 552–8.
   PubMed Web of Science ®Google Scholar
• Wilson RE, Wood RC, Lerner HL, et al. Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma: com-bined results of two randomized trials. Arch Surg 1986; 121: 1354–9.
   PubMedGoogle Scholar
• Edmonson JH. Systemic chemotherapy following complete excision of nonosseous sarcomas: Mayo Clinic experience. Cancer Treat Symp 1985; 3: 89–107.
   Google Scholar
• Bramwell VH, Rouesse J, Santoro A, et al. European experi-ence of adjuvant chemotherapy for soft tissue sarcoma: preliminary report of randomized trial of cyclophosphamide, vincristine, doxorubicin, and dacarbazine. Cancer Treat Symp 1985; 3: 99–107.
   Google Scholar
• Eilber FR, Guiliano AE, Huth JF, et al. Adjuvant Adriamycin in high-grade extremity soft-tissue sarcoma: a randomized prospective trial. Proc Am Soc Clin Oncol 1986; 5: 488.
   Google Scholar
• Alvegard TA. Adjuvant chemotherapy with Adriamycin in high grade malignant soft tissue sarcoma: a Scandinavian randomized study. Proc Am Soc Clin Oncol 1986; 5: 485.
   Google Scholar
• Sarcoma Meta-analysis Collaboration (SMAC) Meta-analysis Group. Adjuvant chemotherapy for localized respectable soft tissue sarcoma in adults. Cochrane Database Syst Rev 2000; 4: CD001419.
   Google Scholar